We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics.
- Authors
Kelaidonis, Konstantinos; Ligielli, Irene; Letsios, Spiros; Vidali, Veroniki P.; Mavromoustakos, Thomas; Vassilaki, Niki; Moore, Graham J.; Hoffmann, Weronika; Węgrzyn, Katarzyna; Ridgway, Harry; Chasapis, Christos T.; Matsoukas, John M.
- Abstract
This study is an extension of current research into a novel class of synthetic antihypertensive drugs referred to as "bisartans", which are bis-alkylated imidazole derivatives bearing two symmetric anionic biphenyltetrazoles. Research to date indicates that bisartans are superior to commercially available hypertension drugs, since the former undergo stronger docking to angiotensin-converting enzyme 2 (ACE2). ACE2 is the key receptor involved in SARS-CoV-2 entry, thus initiating COVID-19 infection and in regulating levels of vasoactive peptides such as angiotensin II and beneficial heptapeptides A(1-7) and Alamandine in the renin–angiotensin system (RAS). In previous studies using in vivo rabbit-iliac arterial models, we showed that Na+ or K+ salts of selected Bisartans initiate a potent dose–response inhibition of vasoconstriction. Furthermore, computational studies revealed that bisartans undergo stable binding to the vital interfacial region between ACE2 and the SARS-CoV-2 "receptor binding domain" (i.e., the viral RBD). Thus, bisartan homologs are expected to interfere with SARS-CoV-2 infection and/or suppress disease expression in humans. The primary goal of this study was to investigate the role of tetrazole in binding and the network of amino acids of SARS-CoV-2 Spike RBD-ACE2 complex involved in interactions with sartans. This study would, furthermore, allow the expansion of the synthetic space to create a diverse suite of new bisartans in conjunction with detailed computational and in vitro antiviral studies. A critical role for tetrazole was uncovered in this study, shedding light on the vital importance of this group in the binding of sartans and bisartans to the ACE2/Spike complex. The in silico data predicting an interaction of tetrazole-containing sartans with ACE2 were experimentally validated by the results of surface plasmon resonance (SPR) analyses performed with a recombinant human ACE2 protein.
- Subjects
ANGIOTENSIN II; SARS-CoV-2; TETRAZOLES; SURFACE plasmon resonance; COVID-19; ANGIOTENSIN converting enzyme; RENIN-angiotensin system
- Publication
International Journal of Molecular Sciences, 2023, Vol 24, Issue 9, p8454
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms24098454